{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-026437","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.560371+00:00","generated_at":"2026-06-14T07:22:05.984475+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"REGENXBIO shareholders elect all three Class II director nominees at annual meeting","bullets":["Jean Bennett, Jerry Karabelas, and Daniel Tassé elected as Class II directors with 30.3M, 35.5M, and 36.0M votes for, respectively.","Ratification of PricewaterhouseCoopers as independent auditor for FY2023 approved: 39.8M for, 50.7K against.","Advisory (non-binding) vote on named executive officer compensation passed with 36.7M for, 1.1M against.","Broker non-votes were 1,965,878 for director election and say-on-pay; none for auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-026437","json":"https://secwatch.observer/filing/0000950170-23-026437.json","markdown":"https://secwatch.observer/filing/0000950170-23-026437.md","text":"https://secwatch.observer/filing/0000950170-23-026437.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/rgnx-20230602.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:22:05.984475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"094e2a75c5ade566ab1f5415dc14873525028240","claim":"REGENXBIO Inc. shareholders approved Advisory vote to approve named executive officer compensation at the 2023-06-02 meeting.","evidence_excerpt":"Proposal 3 : By the following vote, the stockholders approved, on an advisory basis,the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement: Votes For Votes Against Votes Abstaining Broker Non-Votes 36,733,345 1,131,884 111,321 1,965,878","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"26f197fc407b4f241ff57b556ad8594d044a9eba","claim":"REGENXBIO Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-06-02 meeting.","evidence_excerpt":"Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023: Votes For Votes Against Votes Abstaining Broker Non-Votes 39,799,734 50,694 92,000 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"c6530af3d235f47c7b256d794413070113241c1c","claim":"REGENXBIO Inc. shareholders approved Election of three Class II directors at the 2023-06-02 meeting.","evidence_excerpt":"Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company’s 2026 annual meeting of stockholders: Nominee Votes For Votes Withheld Broker Non-Votes Jean Bennett, M.D., Ph.D. 30,318,877 7,665,786 1,965,878 A.N. “Jerry” Karabelas, Ph.D. 35,490,395 2,494,268 1,965,878 Daniel Tassé 35,984,653 2,000,010 1,965,878","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-02"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}